A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults

Frontiers in Medicine

Michelle J. Alfa¹ 

关键词: digestion resistant starch;    elderly;    diabetes;    glucose;    insulin-resistance;    gut microbiome;    prebiotics;   

DOI  :  10.3389/fmed.2017.00260

学科分类：医学（综合）

来源: Frontiers

【 摘 要 】

IntroductionType 2 diabetes (T2D) has reached epidemic proportions in North America. Recent evidence suggests that prebiotics can modulate the gut microbiome, which then plays an important role in regulating lipid metabolism, blood glucose, and insulin sensitivity. As such, prebiotics are appealing potential therapeutic strategies for prediabetes and T2D. The key objectives of this study were to determine the tolerability as well as the glucose and insulin modulating ability of MSPrebiotic® digestion resistant starch (DRS) in healthy mid-age (MID) and elderly (ELD) adults.

【 授权许可】

CC BY